Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1988 2
1989 2
1994 2
1995 1
1999 1
2000 3
2001 3
2002 3
2003 5
2004 2
2005 2
2006 3
2007 6
2008 5
2009 7
2010 4
2011 3
2012 6
2013 8
2014 7
2015 8
2016 12
2017 10
2018 5
2019 9
2020 9
2021 10
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Axial psoriatic arthritis: An update for dermatologists.
Gottlieb AB, Merola JF. Gottlieb AB, et al. J Am Acad Dermatol. 2021 Jan;84(1):92-101. doi: 10.1016/j.jaad.2020.05.089. Epub 2020 Jul 31. J Am Acad Dermatol. 2021. PMID: 32747079 Free article. Review.
Psoriasis is a chronic, immune-mediated, systemic, inflammatory disorder characterized by skin plaques and, often, nail disease and arthritis that contribute to reduced quality of life. ...
Psoriasis is a chronic, immune-mediated, systemic, inflammatory disorder characterized by skin plaques and, often, nail disease …
Management of nail psoriasis.
Thomas L, Azad J, Takwale A. Thomas L, et al. Clin Exp Dermatol. 2021 Jan;46(1):3-8. doi: 10.1111/ced.14314. Epub 2020 Aug 2. Clin Exp Dermatol. 2021. PMID: 32741010 Review.
Management of nail psoriasis is deemed challenging and as a result, it is often left untreated by physicians. Assessing the severity of nail disease can also be difficult in clinical practice. While the Nail Psoriasis Severity Index is used widely in trials, it is t …
Management of nail psoriasis is deemed challenging and as a result, it is often left untreated by physicians. Assessing the severity of n …
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O'Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT. Coates LC, et al. Arthritis Rheumatol. 2016 May;68(5):1060-71. doi: 10.1002/art.39573. Epub 2016 Mar 23. Arthritis Rheumatol. 2016. PMID: 26749174
We conducted literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin disease, and nail disease) and convened a new group to identify pertinent comorbidities and their effect on treatment. ...We develope …
We conducted literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin disease …
Diagnosis using nail matrix.
Richert B, Caucanas M, André J. Richert B, et al. Dermatol Clin. 2015 Apr;33(2):243-55. doi: 10.1016/j.det.2014.12.005. Epub 2015 Feb 21. Dermatol Clin. 2015. PMID: 25828714 Review.
Scoring nail psoriasis.
Klaassen KM, van de Kerkhof PC, Bastiaens MT, Plusjé LG, Baran RL, Pasch MC. Klaassen KM, et al. J Am Acad Dermatol. 2014 Jun;70(6):1061-6. doi: 10.1016/j.jaad.2014.02.010. Epub 2014 Mar 31. J Am Acad Dermatol. 2014. PMID: 24698704
Drug-related nail disease.
Piraccini BM, Alessandrini A. Piraccini BM, et al. Clin Dermatol. 2013 Sep-Oct;31(5):618-26. doi: 10.1016/j.clindermatol.2013.06.013. Clin Dermatol. 2013. PMID: 24079591
Nail involvement in autosomal recessive congenital ichthyosis.
Zaouak A, Chamli A, Ben Mansour N, Jouini W, Fenniche S, Hammami H. Zaouak A, et al. Clin Dermatol. 2022 Jul-Aug;40(4):388-394. doi: 10.1016/j.clindermatol.2022.02.012. Epub 2022 Feb 15. Clin Dermatol. 2022. PMID: 35181410 Review.
Seventy-two percent had nail unit changes involving more than one nail, none had single nail disease, 64% had involvement of fingernails, and 68% had involvement of toenails, with cases including periungual hyperkeratosis (64%), xanthonychia (40%), pachyonychia (40% …
Seventy-two percent had nail unit changes involving more than one nail, none had single nail disease, 64% had involvement of f …
Understanding nail disorders.
Baran R, Kechijian P. Baran R, et al. Eur J Dermatol. 2001 Mar-Apr;11(2):159-62. Eur J Dermatol. 2001. PMID: 11275819 Review.
Nail disease in neonatal abstinence syndrome.
Flanagan KE, Lal K, Blankenship K, Gorji N, Rork J, Wiss K. Flanagan KE, et al. Pediatr Dermatol. 2021 Jul;38(4):787-793. doi: 10.1111/pde.14632. Epub 2021 May 28. Pediatr Dermatol. 2021. PMID: 34047407
Safety of current therapies for onychomycosis.
Ricardo JW, Lipner SR. Ricardo JW, et al. Expert Opin Drug Saf. 2020 Nov;19(11):1395-1408. doi: 10.1080/14740338.2020.1829592. Epub 2020 Oct 12. Expert Opin Drug Saf. 2020. PMID: 32990062 Review.
INTRODUCTION: Onychomycosis is the most common nail disease seen in clinical practice. Treatment options include systemic and topical therapies, as well as devices. ...
INTRODUCTION: Onychomycosis is the most common nail disease seen in clinical practice. Treatment options include systemic and …
129 results